TuHURA Biosciences Inc (HURA)
Healthcare
Biotechnology
2.20 $
+0.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns TuHURA Biosciences Inc (HURA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 55.9% of the shares are freely tradable; institutional investors hold 15.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
15.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
34.6%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
55.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
15.8%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
64Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 3.85 | 2,450,256 | +56.4 | 03/31/2026 |
| Vanguard Group Inc | 3.64 | 2,319,762 | +2.2 | 12/31/2025 |
| Vanguard Capital Management, LLC | 3.26 | 2,074,228 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 1.55 | 986,922 | +49.0 | 03/31/2026 |
| AQR Capital Management LLC | 0.95 | 607,168 | +3,580.3 | 03/31/2026 |
| State Street Corp | 0.81 | 512,913 | +77.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.49 | 1,586,666 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 1.63 | 1,039,921 | +0.9 | 05/29/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 0.71 | 449,267 | +0.0 | 04/30/2026 |
| Fidelity Small Cap Index | 0.67 | 424,542 | +30.4 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.